Research Paper Volume 8, Issue 4 pp 769—776
Rapamycin increases grip strength and attenuates age-related decline in maximal running distance in old low capacity runner rats
Figure 1. Average trajectories of grip strength, maximum running distance, and body weight over time by intervention status and sex. The dashed and solid lines respectively represent rapamycin-treated and placebo group-specific mean trajectories estimated from the linear random effects model that took into account the premature deaths; the triangles and solid cycles respectively represent rapamycin-treated and placebo group-specific cross-sectional means based solely on the survivors at the time of each evaluation.